BA
CVS icon

Ballast Advisors’s CVS Health CVS Stock Holding History

Ballast Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$293K Buy
4,083
+41
+1% +$3.16K 0.09% 93
2025
Q4 		$321K Hold
4,042
– – 0.09% 93
2025
Q3 		$305K Hold
4,042
– – 0.08% 95
2025
Q2 		$279K Hold
4,042
– – 0.08% 91
2025
Q1 		$274K Buy
+4,042
New +$242K 0.09% 91
2024
Q4 		– Sell
-4,092
Closed -$257K – 164
2024
Q3 		$257K Sell
4,092
-176
-4% -$10.3K 0.08% 99
2024
Q2 		$252K Buy
4,268
+2
+0% +$125 0.08% 100
2024
Q1 		$340K Sell
4,266
-250
-6% -$19.1K 0.11% 89
2023
Q4 		$357K Sell
4,516
-755
-14% -$53.7K 0.13% 82
2023
Q3 		$368K Sell
5,271
-623
-11% -$44.1K 0.15% 84
2023
Q2 		$407K Sell
5,894
-731
-11% -$52K 0.15% 72
2023
Q1 		$492K Sell
6,625
-1,201
-15% -$101K 0.2% 55
2022
Q4 		$729K Sell
7,826
-49
-0.6% -$4.73K 0.32% 42
2022
Q3 		$751K Buy
7,875
+2
+0% +$198 0.35% 37
2022
Q2 		$730K Sell
7,873
-21
-0.3% -$2.05K 0.33% 42
2022
Q1 		$799K Buy
7,894
+107
+1% +$11.2K 0.31% 41
2021
Q4 		$803K Sell
7,787
-164
-2% -$15.2K 0.31% 42
2021
Q3 		$675K Buy
7,951
+327
+4% +$27.4K 0.28% 41
2021
Q2 		$636K Hold
7,624
– – 0.27% 43
2021
Q1 		$574K Buy
7,624
+166
+2% +$12.1K 0.26% 46
2020
Q4 		$509K Buy
7,458
+626
+9% +$40.7K 0.26% 48
2020
Q3 		$399K Buy
6,832
+1,005
+17% +$62.5K 0.25% 54
2020
Q2 		$379K Sell
5,827
-9
-0.2% -$567 0.27% 55
2020
Q1 		$346K Buy
5,836
+169
+3% +$11.3K 0.33% 51
2019
Q4 		$421K Buy
+5,667
New +$398K 0.31% 56

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ballast Advisors's CVS Position: Q1 2026 in Review

Ballast Advisors increased its CVS Health (CVS) stake by 1% in Q1 2026, buying an estimated $3.16K and bringing the position to 4,083 shares worth $293K. The position accounts for 0.09% of the portfolio, ranked #93.

Ballast Advisors first reported a position in CVS in Q4 2019 and has held it in 25 quarters since. The position peaked at $803K in Q4 2021. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Ballast Advisors held 4,083 shares of CVS Health worth $293K as of Q1 2026.
  • Ballast Advisors bought 41 CVS Health shares in Q1 2026, an estimated $3.16K.
  • CVS Health made up 0.09% of Ballast Advisors's portfolio in Q1 2026, its #93 holding.
  • Ballast Advisors first reported a position in CVS Health in Q4 2019 and has held it in 25 quarters since.
  • Ballast Advisors's CVS Health position peaked at $803K in Q4 2021.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Ballast Advisors's 13F filing for Q1 2026, filed 13 May 2026.